We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.76B
AUM Growth
+$477M
Cap. Flow
+$295M
Cap. Flow %
10.72%
Top 10 Hldgs %
40.13%
Holding
124
New
45
Increased
34
Reduced
15
Closed
23

Top Buys

Rank Stock Value
1
WSM icon
Williams-Sonoma
WSM
+$39.5M
2
ALKS icon
Alkermes
ALKS
+$38.6M
3
KO icon
Coca-Cola
KO
+$31.2M
4
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$28.8M
5
ALT icon
Altimmune
ALT
+$28.7M

Top Sells

Rank Stock Value
1
DBX icon
Dropbox
DBX
+$35.4M
2
DG icon
Dollar General
DG
+$35.3M
3
BIIB icon
Biogen
BIIB
+$32.4M
4
ATR icon
AptarGroup
ATR
+$32.3M
5
BBY icon
Best Buy
BBY
+$29M

Sector Composition

Rank Sector Weight
1 Healthcare 48.21%
2 Consumer Discretionary 12.09%
3 Consumer Staples 9.81%
4 Industrials 2.38%
5 Technology 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WYNN icon
76
Wynn Resorts
WYNN
$10.5B
$6.03M 0.22%
+84,000
New +$6.66M
UAA icon
77
Under Armour
UAA
$2.73B
$5.95M 0.22%
+530,108
New +$5.58M
PLAN
78
DELISTED
Anaplan, Inc.
PLAN
$5.51M 0.2%
+88,000
New +$4.54M
UBER icon
79
Uber
UBER
$143B
$5.47M 0.2%
150,000
-586,000
-80% -$19.3M
SMAR
80
DELISTED
Smartsheet Inc.
SMAR
$4.94M 0.18%
100,000
-316,000
-76% -$15.3M
EXAS
81
DELISTED
Exact Sciences
EXAS
$4.08M 0.15%
+40,000
New +$3.45M
MNK
82
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$3.89M 0.14%
40,000
– –
AMYT
83
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$3.78M 0.14%
+306,000
New +$3.54M
BIOR
84
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$3.61M 0.13%
+1,600
New +$3.62M
TENX icon
85
Tenax Therapeutics
TENX
$498M
$3.11M 0.11%
+1,262
New +$2.69M
PRFX icon
86
PRF Technologies Ltd
PRFX
$3.35M
$2.94M 0.11%
+532
New +$3.67M
MOTS
87
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$2.81M 0.1%
+9,588
New +$3.22M
TELA icon
88
TELA Bio
TELA
$38.5M
$2.65M 0.1%
+160,000
New +$2.25M
LIVN icon
89
LivaNova
LIVN
$4.16B
$2.26M 0.08%
+50,000
New +$2.42M
ONCT
90
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2.24M 0.08%
65,808
+2,972
+5% +$146K
NERV icon
91
Minerva Neurosciences
NERV
$207M
$1.59M 0.06%
62,500
+25,000
+67% +$676K
ATRS
92
DELISTED
Antares Pharma, Inc.
ATRS
$1.16M 0.04%
+428,000
New +$1.18M
VXRT
93
DELISTED
Vaxart
VXRT
$968K 0.04%
145,523
– –
GOVXW
94
DELISTED
GeoVax Labs Warrants
GOVXW
$845K 0.03%
+391,700
New +$331K
CLRO icon
95
ClearOne Inc
CLRO
$26.2M
$802K 0.03%
+23,333
New +$862K
HIND
96
Vyome Holdings
HIND
$15M
$674K 0.02%
+1
New +$684K
MDGSW
97
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$634K 0.02%
+1,285,715
New +$265K
SYTAW
98
DELISTED
Siyata Mobile Warrant
SYTAW
$485K 0.02%
+150,000
New +$169K
KBNTW
99
DELISTED
Kubient, Inc. Warrant
KBNTW
$367K 0.01%
+275,000
New +$272K
NMRD
100
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$315K 0.01%
+88,830
New +$519K
1 2 3
4
5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Armistice Capital held 124 positions worth $2.76B, up 21% from $2.28B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $295M of net new capital in Q3 2020, opening 45 new positions and adding to 34 existing holdings. Its largest new stake was Williams-Sonoma: 890,000 shares worth $40.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Biogen, an estimated $32.4M trimmed.

  • Armistice Capital's largest Q3 2020 buy was Williams-Sonoma: 890,000 shares worth $40.2M.
  • Armistice Capital added most to AutoZone in Q3 2020, an estimated $27.5M increase.
  • Armistice Capital's biggest Q3 2020 reduction was Biogen, cutting an estimated $32.4M.
  • Armistice Capital fully exited Dropbox in Q3 2020, selling an estimated $35.4M.
  • Armistice Capital's ten largest holdings make up 40% of its $2.76B portfolio in Q3 2020.
  • Armistice Capital opened 45 new positions and closed 23 in Q3 2020.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $2.76B.

Based on Armistice Capital's 13F filing for Q3 2020, filed 16 Nov 2020.